BD to Host Investor Day on December 10, 2026
News related to:BD (Becton, Dickinson and Company) · 1 min read
FRANKLIN LAKES, N.J., Nov. 10, 2026 /CourierPR/ -- Becton, Dickinson and Company (BD) is set to host its annual Investor Day on Thursday, December 10, 2026, in New York City. The event, which will bring together institutional investors and financial analysts, is designed to provide an in-depth look at the company’s strategic direction and financial outlook.
Registration for the event will open at 7:30 a.m. Eastern Time, with the program commencing at 8:30 a.m. The keynote speakers, including Tom Polen, chairman, chief executive officer, and president of BD, and Vitor Roque, executive vice president and chief financial officer, will outline BD’s business strategy, capital deployment priorities, and long-term growth plans. Attendees will also have the opportunity to engage in a question-and-answer session with the leadership team.
In addition to the presentations, in-person attendees will be able to visit BD’s Product Showcase, which will feature innovations that support the company’s long-term growth strategy. The Showcase will be open from 7:30 a.m. to the conclusion of the question-and-answer session.
To participate in the in-person event, attendees are required to register by December 3, 2026. A live webcast of the presentations and Q&A session will be available at investors.bd.com for those unable to attend in person.
BD, a global medical technology leader, operates across the globe with more than 60,000 employees. The company delivers billions of products annually, contributing to the advancement of healthcare worldwide. By collaborating closely with customers, BD aims to enhance clinical operations, improve patient care, and drive innovation in medical essentials, connected care, biopharma systems, and interventional technologies.
The Investor Day event is a significant opportunity for BD to communicate its vision and strategies to key stakeholders, ensuring transparency and fostering a deeper understanding of the company’s role in the global healthcare landscape.